Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Quantitative phosphoproteomic analysis of IL-33-mediated signaling
Indexado
WoS WOS:000347895500032
Scopus SCOPUS_ID:84921321002
DOI 10.1002/PMIC.201400303
Año 2015
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Interleukin-33 (IL-33) is a novel member of the IL-1 family of cytokines that plays diverse roles in the regulation of immune responses. IL-33 exerts its effects through a heterodimeric receptor complex resulting in the production and release of proinflammatory cytokines. A detailed understanding of the signaling pathways activated by IL-33 is still unclear. To gain insights into the IL-33-mediated signaling mechanisms, we carried out a SILAC-based global quantitative phosphoproteomic analysis that resulted in the identification of 7191 phosphorylation sites derived from 2746 proteins. We observed alterations in the level of phosphorylation in 1050 sites corresponding to 672 proteins upon IL-33 stimulation. We report, for the first time, phosphorylation of multiple protein kinases, including mitogen-activated protein kinase activated protein kinase 2 (Mapkapk2), receptor (TNFRSF) interacting serine-threonine kinase 1 (Ripk1), and NAD kinase (Nadk) that are induced by IL-33. In addition, we observed IL-33-induced phosphorylation of several protein phosphatases including protein tyrosine phosphatase, nonreceptor-type 12 (Ptpn12), and inositol polyphosphate-5-phosphatase D (Inpp5d), which have not been reported previously. Network analysis revealed an enrichment of actin binding and cytoskeleton reorganization that could be important in macrophage activation induced by IL-33. Our study is the first quantitative analysis of IL-33-regulated phosphoproteome. Our findings significantly expand the understanding of IL-33-mediated signaling events and have the potential to provide novel therapeutic targets pertaining to immune-related diseases such as asthma where dysregulation of IL-33 is observed. All MS data have been deposited in the ProteomeXchange with identifier PXD000984 (http://proteomecentral.proteomexchange.org/dataset/PXD000984).

Revista



Revista ISSN
Proteomics 1615-9853

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Biochemistry & Molecular Biology
Biochemical Research Methods
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Pinto, Sneha M. Mujer Inst Bioinformat - India
Manipal Univ - India
Johns Hopkins Univ - Estados Unidos
International Technology Park - India
Manipal Academy of Higher Education - India
Johns Hopkins School of Medicine - Estados Unidos
2 Nirujogi, Raja Sekhar Hombre Inst Bioinformat - India
Pondicherry Univ - India
International Technology Park - India
Pondicherry University - India
3 LEAL-ROJAS, PAMELA ALEJANDRA Mujer Johns Hopkins Univ - Estados Unidos
Universidad de La Frontera - Chile
3 Rojas, Pamela Leal Mujer Johns Hopkins School of Medicine - Estados Unidos
Universidad de La Frontera - Chile
Johns Hopkins Univ - Estados Unidos
4 Patil, Arun H. Hombre Inst Bioinformat - India
KIIT Univ - India
International Technology Park - India
Kalinga Institute of Industrial Technology, Bhubaneswar - India
5 Manda, Srikanth Srinivas - Inst Bioinformat - India
Pondicherry Univ - India
International Technology Park - India
Pondicherry University - India
6 Subbannayya, Yashwanth - Inst Bioinformat - India
International Technology Park - India
7 FIGUEROA-DURAN, JUAN CARLOS Hombre Pontificia Universidad Católica de Chile - Chile
8 Chatterjee, Aditi Mujer Inst Bioinformat - India
International Technology Park - India
9 Prasad, T. S. Keshava - Inst Bioinformat - India
Manipal Univ - India
International Technology Park - India
Manipal Academy of Higher Education - India
10 Pandey, Akhilesh - Johns Hopkins Univ - Estados Unidos
Adrienne Helis Malvin Med Res Fdn - Estados Unidos
Diana Helis Henry Med Res Fdn - Estados Unidos
Johns Hopkins School of Medicine - Estados Unidos
Adrienne Helis Malvin Medical Research Foundation - Estados Unidos
Diana Helis Henry Medical Research Foundation - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
NIH
National Institute of General Medical Sciences
DBT
Department of Biotechnology (DBT), Government of India
Council of Scientific and Industrial Research (CSIR), Government of India
University Grants Commission (UGC), India

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
The MS proteomics data in this paper have been deposited in the ProteomeXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner repository [30]: dataset identifier PXD000984. We thank the Department of Biotechnology (DBT), Government of India for research support to the Institute of Bioinformatics. S.M.P. and R.S.N. are recipients of Senior Research Fellowship from Council of Scientific and Industrial Research (CSIR), Government of India. S.S.M. and Y.S. are recipients of Senior Research Fellowship from the University Grants Commission (UGC), India. T.S.K.P. is supported by DBT Program Support on Neuroproteomics (BT/01/COE/08/05) to IOB. This work was supported by an NIH roadmap grant for Technology Centers of Networks and Pathways (U54GM103520). The authors acknowledge the joint participation by the Adrienne Helis Malvin Medical Research Foundation and the Diana Helis Henry Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with The Johns Hopkins Hospital and the Johns Hopkins University School of Medicine and the Foundation's Parkinson's disease Programs.

Muestra la fuente de financiamiento declarada en la publicación.